featured
Resmetirom Therapy for the Management of Patients With MASLD: Updates to the AASLD Practice Guidance
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Hepatology 2025 Jan 01;81(1)312-320, VL Chen, TR Morgan, Y Rotman, HM Patton, K Cusi, F Kanwal, WR KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.